Travere Therapeutics
TVTX
TVTX
108 hedge funds and large institutions have $792M invested in Travere Therapeutics in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 43 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
-6
Holders Change %
-5.26%
% of All Funds
2.7%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
10
Increased
43
Reduced
37
Closed
15
Calls
$8.01M
Puts
$1.69M
Net Calls
+$6.32M
Net Calls Change
+$34K
Top Buyers
| 1 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
+$9.76M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$5.94M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.27M |
| 4 |
Goldman Sachs
New York
|
+$3.55M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.34M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$6.73M |
| 2 |
Millennium Management
New York
|
-$6.38M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.9M |
| 4 |
SAM
Senzar Asset Management
New York
|
-$3.57M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.02M |
